查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1938713

2026年全球獸用生技藥品市場報告

Veterinary Biologics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，獸用生物製藥市場成長顯著，預計將以7.3%的複合年成長率成長，從2025年的136.1億美元成長到2026年的146.1億美元。過去幾年的成長可能歸因於以下因素：牲畜疾病的日益普及、伴侶動物數量的增加、疫苗研發的進步、政府對獸醫研究投入的增加以及獸醫醫療基礎設施的擴張。

預計未來幾年獸用生技藥品市場將維持強勁成長，2030年市場規模將達200.3億美元，複合年成長率（CAGR）為8.2%。預測期內的成長要素包括生技藥品技術的進步、動物精準醫療的日益普及、全球寵物飼養率的上升、人們對通用感染疾病的意識提升以及獸用診斷市場的發展。預測期內的主要趨勢包括：更加重視預防性獸醫學、快速診斷解決方案的日益普及、伴侶動物生技藥品的擴張、免疫調節劑在獸醫學中的應用以及對牲畜疾病管理解決方案需求的成長。

預計未來幾年，寵物飼養量的成長將推動獸用生物製藥市場的發展。寵物飼養是指從收容所和救援機構領養家養動物，並承擔起為它們提供永久、充滿愛心的家的責任。隨著動物福利意識的提高，越來越多的人認知到照顧救援動物的好處，並擴大選擇飼養而非購買，導致寵物飼養量的成長。獸用生技藥品有助於預防寵物的各種感染疾病，提供免疫力，控制通用感染疾病，延長寵物壽命並提高其生活品質，降低獸醫醫療成本，促進生殖健康，並提供更有針對性和個性化的治療方案。例如，根據美國寵物用品協會2025年3月發布的數據，美國擁有一隻或多隻寵物的家庭數量將達到9,400萬戶，高於2023年的8,200萬戶。寵物飼養量的成長正在推動獸用生技藥品市場的發展。

獸用生技藥品市場的主要企業致力於開發創新生技藥品，例如疫苗，以改善動物健康並預防疾病。疫苗是一種能夠刺激免疫系統識別並攻擊特定病原體的物質，從而提供適應性免疫並幫助預防感染疾病。例如，2024年8月，總部位於美國的全球動物保健公司默克動物保健宣布，其針對禽偏肺病毒（aMPV）B型的實驗性自體疫苗已獲得美國農業部（USDA）的生產和銷售核准。該疫苗由默克動物保健與劍橋科技公司合作開發，旨在對抗自2023年底以來一直在家禽中引起嚴重呼吸道疾病並造成重大經濟損失的aMPV B型。該疫苗在明尼蘇達州一家先進的工廠生產，採用油包水乳劑配方，旨在減少接種後的組織反應，填補了此前市場上尚無商業許可疫苗的重要空白。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球獸用生技藥品市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
    • 生物技術、基因組學和精準醫學
  • 主要趨勢
    • 越來越重視預防性獸醫護理
    • 快速診斷解決方案的應用日益廣泛
    • 擴大伴侶動物生物製藥的應用
    • 免疫調節劑在獸醫學的應用
    • 對牲畜疾病管理解決方案的需求不斷成長

第5章 終端用戶產業市場分析

  • 獸醫診所
  • 獸醫診所
  • 畜牧場
  • 研究和診斷實驗室
  • 動物健康組織

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球獸用生技藥品市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球獸用生技藥品市場規模、對比及成長率分析
  • 全球獸用生技藥品市場表現：規模與成長，2020-2025年
  • 全球獸用生技藥品市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 疫苗、診斷試劑盒、免疫調節劑、抗血清和抗體等產品
  • 依疾病類型
  • 藍探戈病、口蹄疫、布氏桿菌症、結核病等疾病類型
  • 透過分銷管道
  • 獸醫院、動物診所和其他通路
  • 透過使用
  • 生產動物、伴侶動物
  • 按類型細分：疫苗
  • 活病毒疫苗、不活化疫苗、重組疫苗、DNA疫苗
  • 按類型細分：診斷試劑盒
  • 快速檢測套組、ELISA試劑盒、基於PCR的診斷試劑盒
  • 按類型細分：免疫調節劑
  • 細胞激素、佐劑和免疫促效劑
  • 按類型細分：抗血清和抗體
  • 單株抗體、多株抗體、高免疫血清
  • 按類型細分：其他產品
  • 益生菌、益生元、生長因子、類毒素

第10章 區域與國家分析

  • 全球獸用生技藥品市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球獸用生技藥品市場：依國家分類，實際值及預測值，2020-2025年、2025-2030年預測值、2035年預測值

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 獸用生技藥品市場：競爭格局及市場佔有率（2024年）
  • 獸用生技藥品市場：公司估價矩陣
  • 獸用生技藥品市場：公司概況
    • Zoetis Inc.
    • Merck Animal Health Inc.
    • Boehringer Ingelheim Animal Health Inc.
    • Elanco Animal Health
    • IDEXX Laboratories Inc.

第37章：其他領先和創新企業

  • Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale SA, Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年獸用生技藥品市場：提供新機會的國家
  • 2030年獸用生技藥品市場：蘊藏新機會的細分市場
  • 2030年獸用生技藥品市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: VH4MVBIO02_G26Q1

Veterinary biologics encompass biological products obtained from living organisms such as viruses, bacteria, or other microorganisms. These specialized products in veterinary medicine serve to prevent, diagnose, or treat diseases in animals.

Key products falling under veterinary biologics include vaccines, diagnostic kits, immunomodulators, antiserums, antibodies, and related items. Vaccines, for instance, are formulated to trigger the immune system's response and offer protection against specific animal diseases. They address various ailments such as bluetongue, foot and mouth disease, brucellosis, tuberculosis, and others. These products are distributed through multiple channels, including veterinary hospitals and clinics, for diverse applications involving both production and companion animals.

Tariffs have impacted the veterinary biologics market by increasing the cost of imported vaccines, diagnostic kits, and immunomodulators, leading to supply chain disruptions in regions such as North America and Europe. Production animal biologics and high-value companion animal products are the most affected segments. While tariffs have raised costs, they have also encouraged local manufacturing and innovation in biologics production, helping regional companies expand capabilities and reduce dependency on imports.

The veterinary biologics market research report is one of a series of new reports from The Business Research Company that provides veterinary biologics market statistics, including veterinary biologics industry global market size, regional shares, competitors with a veterinary biologics market share, detailed veterinary biologics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biologics industry. This veterinary biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary biologics market size has grown strongly in recent years. It will grow from $13.61 billion in 2025 to $14.61 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to growing prevalence of livestock diseases, rise in companion animal population, advancements in vaccine development, increased government funding for veterinary research, expansion of veterinary healthcare infrastructure.

The veterinary biologics market size is expected to see strong growth in the next few years. It will grow to $20.03 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to technological advancements in biologics, increasing adoption of precision medicine in animals, rise in global pet ownership, growing awareness about zoonotic diseases, expansion of veterinary diagnostics market. Major trends in the forecast period include increased focus on preventive animal healthcare, growing adoption of rapid diagnostic solutions, expansion of companion animal biologics, integration of immunomodulators in veterinary treatments, rising demand for livestock disease management solutions.

The growing adoption of pets is expected to drive the growth of the veterinary biologics market in the coming years. Pet adoption involves taking responsibility for a domesticated animal, often from a shelter or rescue organization, and providing it with a permanent and caring home. The adoption of pets is increasing due to greater awareness of animal welfare, as more individuals recognize the advantages of adopting rescued animals and increasingly choose adoption over purchasing pets. Veterinary biologics help prevent a wide range of infectious diseases in pets, provide immunity, control zoonotic diseases, improve lifespan and quality of life, reduce veterinary healthcare costs, enhance reproductive health, and enable more targeted and customized treatment options. For example, in March 2025, the American Pet Products Association, a US-based non-profit organization, reported that 94 million US households owned at least one pet, compared with 82 million households in 2023. Therefore, the rising adoption of pets is contributing to the growth of the veterinary biologics market.

Leading companies in the veterinary biologics market are concentrating on the development of innovative biologics, such as vaccines, to improve animal health and prevent diseases. A vaccine is a substance that triggers the immune system to recognize and combat specific pathogens, helping to prevent infectious diseases by providing acquired immunity. For example, in August 2024, Merck Animal Health, a global animal health company based in the U.S., launched an experimental autogenous vaccine targeting avian metapneumovirus (aMPV) type B, which received approval from the U.S. Department of Agriculture (USDA) for manufacturing and sale. Created in partnership with Cambridge Technologies, this vaccine aims to address the serious respiratory problems caused by aMPV type B in poultry, which have resulted in significant economic losses since late 2023. Manufactured at a state-of-the-art facility in Minnesota, the vaccine uses an oil and water emulsion formulation designed to reduce post-vaccination tissue reactions, filling a crucial gap in the market as there were previously no commercially licensed vaccines available.

In January 2024, Ceva Sante Animale, a pharmaceutical company based in France, acquired Scout Bio for an undisclosed amount. This acquisition enhances Ceva's biotechnology capabilities and speeds up its innovation in pet therapeutics, particularly targeting advanced treatments for chronic diseases. This strategic move responds to the growing demand for better health solutions among pet owners. Scout Bio is a biotechnology company located in the U.S. that specializes in providing essential data for the development of effective veterinary biologics, including vaccines and diagnostics.

Major companies operating in the veterinary biologics market are Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA, Indian Immunologicals Ltd., Vetoquinol, Beijing SVA Vaccines Serums

North America was the largest region in the veterinary biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary biologics market consists of sales of transplant tissues, recombinant proteins, and stem cells. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Biologics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Vaccines; Diagnostic Kits; Immunomodulators; Antiserums And Antibodies; Other Products
  • 2) By Disease Type: Bluetongue; Foot And Mouth Disease; Brucellosis And Tuberculosis; Other Disease Types
  • 3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Other Distribution Channels
  • 4) By Application: Production Animal; Companion Animal
  • Subsegments:
  • 1) By Vaccines: Live Attenuated Vaccines; Inactivated Vaccines; Recombinant Vaccines; DNA Vaccines
  • 2) By Diagnostic Kits: Rapid Tests; Elisa Kits; Pcr-Based Diagnostic Kits
  • 3) By Immunomodulators: Cytokines; Adjuvants; Immunostimulants
  • 4) By Antiserums And Antibodies: Monoclonal Antibodies; Polyclonal Antibodies; Hyperimmune Serums
  • 5) By Other Products: Probiotics; Prebiotics; Growth Factors; Toxoids
  • Companies Mentioned: Zoetis Inc.; Merck Animal Health Inc.; Boehringer Ingelheim Animal Health Inc.; Elanco Animal Health; IDEXX Laboratories Inc.; Virbac SA; Phibro Animal Health Corporation; Abaxis Inc.; Bimeda Biologicals; Ceva Sante Animale S.A.; Heska Corporation; Colorado Serum Company; Hester Biosciences Limited; INDICAL Bioscience GmbH; Intervet Inc.; Hebei Veyong Animal Pharmaceutical Co. Ltd.; Biomet Biologics LLC; CytoDyn Veterinary Medicine LLC; KM Biologics; HIPRA; Indian Immunologicals Ltd.; Vetoquinol; Beijing SVA Vaccines Serums
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Veterinary Biologics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Veterinary Biologics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Veterinary Biologics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Veterinary Biologics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Increased Focus On Preventive Animal Healthcare
    • 4.2.2 Growing Adoption Of Rapid Diagnostic Solutions
    • 4.2.3 Expansion Of Companion Animal Biologics
    • 4.2.4 Integration Of Immunomodulators In Veterinary Treatments
    • 4.2.5 Rising Demand For Livestock Disease Management Solutions

5. Veterinary Biologics Market Analysis Of End Use Industries

  • 5.1 Veterinary Hospitals
  • 5.2 Veterinary Clinics
  • 5.3 Livestock Farms
  • 5.4 Research & Diagnostic Laboratories
  • 5.5 Animal Health Organizations

6. Veterinary Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Biologics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Veterinary Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Veterinary Biologics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Veterinary Biologics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Veterinary Biologics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Biologics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Biologics Market Segmentation

  • 9.1. Global Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
  • 9.2. Global Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types
  • 9.3. Global Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
  • 9.4. Global Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Production Animal, Companion Animal
  • 9.5. Global Veterinary Biologics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines
  • 9.6. Global Veterinary Biologics Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits
  • 9.7. Global Veterinary Biologics Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cytokines, Adjuvants, Immunostimulants
  • 9.8. Global Veterinary Biologics Market, Sub-Segmentation Of Antiserums And Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums
  • 9.9. Global Veterinary Biologics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Probiotics, Prebiotics, Growth Factors, Toxoids

10. Veterinary Biologics Market Regional And Country Analysis

  • 10.1. Global Veterinary Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Veterinary Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Biologics Market

  • 11.1. Asia-Pacific Veterinary Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Biologics Market

  • 12.1. China Veterinary Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Biologics Market

  • 13.1. India Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Biologics Market

  • 14.1. Japan Veterinary Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Biologics Market

  • 15.1. Australia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Biologics Market

  • 16.1. Indonesia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Biologics Market

  • 17.1. South Korea Veterinary Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Biologics Market

  • 18.1. Taiwan Veterinary Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Biologics Market

  • 19.1. South East Asia Veterinary Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Biologics Market

  • 20.1. Western Europe Veterinary Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Biologics Market

  • 21.1. UK Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Biologics Market

  • 22.1. Germany Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Biologics Market

  • 23.1. France Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Biologics Market

  • 24.1. Italy Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Biologics Market

  • 25.1. Spain Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Biologics Market

  • 26.1. Eastern Europe Veterinary Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Biologics Market

  • 27.1. Russia Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Biologics Market

  • 28.1. North America Veterinary Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Biologics Market

  • 29.1. USA Veterinary Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Biologics Market

  • 30.1. Canada Veterinary Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Biologics Market

  • 31.1. South America Veterinary Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Biologics Market

  • 32.1. Brazil Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Biologics Market

  • 33.1. Middle East Veterinary Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Biologics Market

  • 34.1. Africa Veterinary Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Veterinary Biologics Market, Segmentation By Product, Segmentation By Disease Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Biologics Market Regulatory and Investment Landscape

36. Veterinary Biologics Market Competitive Landscape And Company Profiles

  • 36.1. Veterinary Biologics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Veterinary Biologics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Veterinary Biologics Market Company Profiles
    • 36.3.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boehringer Ingelheim Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Elanco Animal Health Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Biologics Market Other Major And Innovative Companies

  • Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA

38. Global Veterinary Biologics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Biologics Market

40. Veterinary Biologics Market High Potential Countries, Segments and Strategies

  • 40.1 Veterinary Biologics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Veterinary Biologics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Veterinary Biologics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer